PDCD1 and neoplasm: Meanwhile, concomitant inhibition of cMET and PD1 blocked the infiltration of bone marrow-derived immunosuppressive neutrophils into the tumor and led the way for the anti-tumor efficacy of PD1 inhibitors in mouse tumor models (64).